Next Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$742K Buy
38,560
+5,793
+18% +$117K 0.05% 397
2021
Q3
$682K Buy
32,767
+2,836
+9% +$60.7K 0.05% 365
2021
Q2
$642K Buy
29,931
+2,403
+9% +$48.5K 0.05% 375
2021
Q1
$543K Buy
27,528
+710
+3% +$14.6K 0.05% 395
2020
Q4
$530K Buy
26,818
+2,722
+11% +$50.3K 0.05% 355
2020
Q3
$424K Buy
24,096
+1,526
+7% +$27.3K 0.05% 370
2020
Q2
$405K Buy
22,570
+774
+4% +$13.3K 0.05% 335
2020
Q1
$327K Buy
21,796
+3,169
+17% +$51.9K 0.04% 376
2019
Q4
$325K Buy
18,627
+4,600
+33% +$75.5K 0.03% 496
2019
Q3
$212K Buy
14,027
+225
+2% +$3.6K 0.02% 651
2019
Q2
$233K Buy
+13,802
New +$227K 0.03% 608
2017
Q3
Sell
-1,032
Closed -$22K 1841
2017
Q2
$22K Buy
1,032
+19
+2% +$384 0.01% 1037
2017
Q1
$21K Sell
1,013
-617
-38% -$11.4K 0.01% 1031
2016
Q4
$28K Buy
1,630
+36
+2% +$632 ﹤0.01% 1213
2016
Q3
$30K Buy
1,594
+660
+71% +$12.4K 0.01% 1175
2016
Q2
$16K Sell
934
-135
-13% -$2.49K 0.01% 1043
2016
Q1
$19K Hold
1,069
0.01% 955
2015
Q4
$25K Buy
1,069
+192
+22% +$4.76K 0.01% 852
2015
Q3
$19K Buy
877
+18
+2% +$504 0.01% 965
2015
Q2
$24K Buy
859
+15
+2% +$416 0.01% 928
2015
Q1
$23K Buy
844
+14
+2% +$382 0.01% 938
2014
Q4
$21K Sell
830
-1,758
-68% -$42.2K 0.01% 960
2014
Q3
$57K Buy
2,588
+2,078
+407% +$45.1K 0.01% 878
2014
Q2
$11K Buy
+510
New +$10.7K 0.01% 765

Other funds holding HQL

Next Financial Group's HQL Position: Q4 2021 in Review

Next Financial Group increased its abrdn Life Sciences Investors (HQL) stake by 18% in Q4 2021, buying an estimated $117K and bringing the position to 38,560 shares worth $742K. The position accounts for 0.05% of the portfolio, ranked #397.

Next Financial Group first reported a position in HQL in Q2 2014 and has held it in 24 quarters since. 67 funds tracked by Wall St. Rank hold HQL as of Q4 2021.

  • Next Financial Group held 38,560 shares of abrdn Life Sciences Investors worth $742K as of Q4 2021.
  • Next Financial Group bought 5,793 abrdn Life Sciences Investors shares in Q4 2021, an estimated $117K.
  • abrdn Life Sciences Investors made up 0.05% of Next Financial Group's portfolio in Q4 2021, its #397 holding.
  • Next Financial Group first reported a position in abrdn Life Sciences Investors in Q2 2014 and has held it in 24 quarters since.
  • 67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.